Recruiting Myelofibrosis Studies in La Jolla
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
This clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptim...
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermediate-2 or high-risk Myelofibrosis (MF) who are rela...
About Myelofibrosis Clinical Trials in La Jolla
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 2 myelofibrosis clinical trials recruiting participants in La Jolla, CA. These studies are seeking a combined 920 participants. Research is being sponsored by Kartos Therapeutics, Inc., Geron Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in La Jolla — FAQ
Are there myelofibrosis clinical trials in La Jolla?
Yes, there are 2 myelofibrosis clinical trials currently recruiting in La Jolla, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in La Jolla?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Jolla research site will contact you about next steps.
Are clinical trials in La Jolla free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Jolla studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 2 active trials in La Jolla are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov